Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABEONA THERAPEUTICS INC.ABEO · Entity 5808 | Director · 10% owner | May 25, 2021 | May 28, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABEONA THERAPEUTICS INC.
Report date May 25, 2021 · Filed May 28, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 533,590 |
Reported balance
After 2021-05-25 transaction · row 1
1 source rowRow 1 · 2021-05-25 · Grant · Acquired 38,590 · Balance 533,590 F1: All of the restricted stock will vest on November 25, 2021. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.49 · Expires 2031-05-25 | Direct | 49,084 |
Reported balance
After 2021-05-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-25 · Grant · Acquired 49,084 · Balance 49,084 F2: All of the stock options will vest on November 25, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the restricted stock will vest on November 25, 2021.
F2: All of the stock options will vest on November 25, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2021 Filed May 28, 2021 01:42 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 49,084 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001493152-21-013115 · ownership.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,084 Underlying: Common Stock · 49,084 shares Expires 2031-05-25 F2 · derivative.exercise_date: All of the stock options will vest on November 25, 2021. Read SEC document |
| May 25, 2021 Filed May 28, 2021 01:42 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 38,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-013115 · ownership.xml · nonDerivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,590 F1 · shares: All of the restricted stock will vest on November 25, 2021. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.01 | $160,888.00 |
DisclosureSEC source: 0001493152-21-010518 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,079,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 18, 2021 Filed Mar 19, 2021 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.23 | $178,624.00 |
DisclosureSEC source: 0001493152-21-006427 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,159,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.13 to $2.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 120,000 | $2.97 | $356,808.00 |
DisclosureSEC source: 0001493152-21-004255 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,239,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.71 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 00:42 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 240,000 | $3.01 | $722,832.00 |
DisclosureSEC source: 0001493152-21-003285 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,359,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 19, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 207,117 | $2.08 | $431,217.59 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 3 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,599,292 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 81,283 | $2.02 | $164,085.99 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 2 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,806,409 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 23:48 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 31,600 | $2.00 | $63,212.64 |
DisclosureSEC source: 0001493152-21-001363 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,887,692 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 80,000 | Not disclosed Strike: $18.50 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 16 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2024-03-07 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F8 · derivative.exercise_date: The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 80,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 15 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2024-03-07 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F8 · derivative.exercise_date: The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $7.34 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 14 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2025-05-11 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F7 · derivative.exercise_date: The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 13 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2025-05-11 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F7 · derivative.exercise_date: The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $2.31 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 12 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2026-02-11 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F6 · derivative.exercise_date: The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 11 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2026-02-11 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F6 · derivative.exercise_date: The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $4.45 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 10 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2026-12-13 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F5 · derivative.exercise_date: The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 9 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2026-12-13 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F5 · derivative.exercise_date: The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $16.00 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 8 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2027-12-14 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F4 · derivative.exercise_date: The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 7 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2027-12-14 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F4 · derivative.exercise_date: The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $7.24 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 6 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2029-04-09 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F3 · derivative.exercise_date: The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 5 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2029-04-09 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F3 · derivative.exercise_date: The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 153,244 | Not disclosed Strike: $1.45 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 4 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153,244 shares Expires 2030-03-16 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F1 · derivative.exercise_date: The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 153,244 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 3 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,244 Underlying: Common Stock · 153,244 shares Expires 2030-03-16 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F1 · derivative.exercise_date: The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | Disposition to issuerStock Option (right to buy) · Derivative | 86,756 | Not disclosed Strike: $3.20 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,756 shares Expires 2030-03-16 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F1 · derivative.exercise_date: The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| November 20, 2020 Filed Nov 20, 2020 23:00 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock Option (right to buy) · Derivative | 86,756 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001493152-20-022146 · ownership.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,756 Underlying: Common Stock · 86,756 shares Expires 2030-03-16 F2 · price: The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. F1 · derivative.exercise_date: The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 1,989 | $2.00 | $3,981.38 |
DisclosureSEC source: 0001493152-20-017963 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,919,292 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F2 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 00:35 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 4,600 | $2.01 | $9,243.70 |
DisclosureSEC source: 0001493152-20-017788 · ownership.xml · nonDerivative · entry 2 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,921,281 F2 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F3 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| September 10, 2020 Filed Sep 15, 2020 00:35 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 73,411 | $2.08 | $152,481.99 |
DisclosureSEC source: 0001493152-20-017788 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · Director · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,925,881 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.01 to $2.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F3 · price: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:05 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | SaleCommon Stock | 80,000 | $2.85 | $228,312.00 |
DisclosureSEC source: 0001493152-20-016305 · ownership.xml · nonDerivative · entry 1 SCO CAPITAL PARTNERS LLC · CIK 0001225978 · 10% owner Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · SCO Capital Partners LLC Disclosed balance after: 11,999,292 F1 · kind: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.81 to $2.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote. F2 · price: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:15 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantEmployee Stock Option (right to buy) · Derivative | 86,756 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001493152-20-009764 · ownership.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,756 Underlying: Common Stock · 86,756 shares Expires 2030-05-20 F2 · derivative.exercise_date: The stock options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:15 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-009764 · ownership.xml · nonDerivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,000 F1 · shares: The restricted stock will vest 25% on March 31, 2021, and in three equal annual installments thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 20:36 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantEmployee Stock Option (right to buy) · Derivative | 153,244 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-20-004255 · ownership.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,244 Underlying: Common Stock · 153,244 shares Expires 2030-03-16 F2 · security: Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the "2015 Plan") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Rouhandeh will also be entitled to an additional grant of 86,756 stock options and a grant of 120,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date. F1 · derivative.exercise_date: The awards will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 23:06 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019359 · tv518749_4.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:16 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000001 · primary_doc.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common stock · 90,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:16 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantSrock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000001 · primary_doc.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:36 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000050 · primary_doc.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common stock · 150,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:36 UTC | ABEONA THERAPEUTICS INC. ABEO · Entity 5808 | GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000050 · primary_doc.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.